In the present work, we investigated the role of co-translational protein aggregation, particularly the cytoplasmic aggregation of RPB1, in tumor cells from biopsy samples of patients with invasive carcinoma of NST to determine its potential as a predictor of chemotherapy resistance. This evidence concerns the gene POLR2A and neoplasm.